HOME >> MEDICINE >> NEWS
Better survival seen for early breast cancer patients switched from tamoxifen to Aromasin

on cancers occurring in women with more than one million women diagnosed each year worldwide. "The Aromasin overall survival data announced today means that women are moving closer to the goal of longer survival." said Lead US Investigator, Stephen Jones, M.D., medical director, and co-chair, breast cancer research committee of the US Oncology Research Network and director of breast cancer research at the Texas Oncology Baylor-Sammons Cancer Center in Dallas.

With the new 5 year follow-up data, no clinically meaningful changes in the safety profile were noted. According to Professor Coombes, "We have also now been able to study the long-term effects of exemestane after completion of therapy, and our results provide women and their physicians with important long-term information on the use of exemestane."

At 34.5 months of follow-up, the most common side effects were mild-to-moderate and include hot flushes (21.2% for Aromasin vs. 19.9% for tamoxifen), fatigue (16.1% vs. 14.7%), arthralgia (14.6% vs. 8.6%), headache (13.1% vs. 10.8%), insomnia (12.4% vs. 8.9%), and increased sweating (11.8% vs. 10.4%). AROMASIN should not be used in women who are premenopausal, are nursing or pregnant, have a known hypersensitivity to the drug, or are taking estrogen-containing agents. Dose modification is recommended for patients who are receiving certain medications, including strong CYP 3A4 inducers. In patients with early breast cancer, elevations in bilirubin, alkaline phosphatase, and creatinine were more common in those receiving AROMASIN than either tamoxifen or placebo.

Aromasin was approved in the United States in 2005 for treatment of postmenopausal women with estrogen-receptor positive early breast cancer following two-to-three years of tamoxifen, for a combined total of five consecutive years of therapy. It also is approved for use in Canada, Europe, Japan and South America. Currently, Aromasin is available in more than 80 countries and approved
'"/>


3-Jun-2006


Page: 1 2 3

Related medicine news :

1. Better mobility keeps seniors healthier
2. Better insight into brain anatomical structures
3. Better health twice as likely for nonsmokers who live and work with smoking restrictions
4. Better designed roadway intersections can boost older drivers performance
5. Better strategies for osteoporosis prevention and therapy
6. Better review of new technology is needed to reduce health costs
7. Better training needed to reduce emergency caesareans
8. Better after-school snack choices boost nutrition for low-income kids, UC Davis research confirms
9. Outcomes of patients in trials; Better blood pressure treatment; Snake bites, and more
10. Better regulation needed for ethical research in Africa
11. Better procedures needed on care of prisoners in hospitals

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... (PRWEB) , ... September 03, 2020 , ... ... it is sponsoring the American Foundation for Suicide Prevention’s (AFSP) annual signature event, ... million people across hundreds of U.S. cities to raise awareness of suicide prevention. ...
(Date:9/3/2020)... ... September 03, 2020 , ... The American ... held Wednesday, April 7, to Saturday, April 10, 2021, at Wynn Las Vegas. ... is a national trade show for non-invasive medical aesthetic practices that brings together ...
(Date:9/3/2020)... ... 03, 2020 , ... International Dark-Sky Association (IDA) recently bestowed ... controller. This advanced LED wireless dimming controller, along with the previously IDA approved ... sky against light pollution. Leo Smith, the Northeast Regional Director for IDA says ...
(Date:9/1/2020)... ... September 01, 2020 , ... Board certified plastic surgeon Sepideh ... office will be the first to bear her name, Dr. Saber has regularly ... lift), as well as rhinoplasty, facial rejuvenation, and many more in association with ...
(Date:9/1/2020)... ... September 01, 2020 , ... Feeding Matters , ... children with Pediatric Feeding Disorder (PFD), is pleased to announce that the U.S. Centers ... diagnostic code (R code) in the next edition of the U.S. International Classification ...
Breaking Medicine News(10 mins):
(Date:9/2/2020)... Md. (PRWEB) , ... September 02, 2020 , ... ... Dr. Jonathan Lee . Dr. Lee will work at Bethesda Dermatopathology Lab. ... with his B.A. from the University of California, Berkley. He went on to receive ...
(Date:9/1/2020)... ... , ... Breast and ovarian cancers are common diseases that affect many women. ... (about 7,500 women per year) and 10% of ovarian cancers (about 2,000 women per ... are detectable in the Women’s Excellence Genetic Testing Program. , Dr. Jonathan Zaidan, MD, ...
(Date:8/31/2020)... SEATTLE (PRWEB) , ... August 31, 2020 , ... ... technology research and advisory guide, has named Cloudticity a Gold winner in the ... are industry and peer recogniti o ns from Network Products Guide ...
Breaking Medicine Technology:
Cached News: